- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
A First Pass at Molycorp’s Q3 Rare Earth Earnings
Seeking Alpha reports Molycorp’s (NYSE:MCP) recorded sales of 217 mt of REO product from Silmet.
Seeking Alpha reports Molycorp’s (NYSE:MCP) recorded sales of 217 mt of REO product from Silmet.
The market news is quoted as saying,
Listening to the earnings conference call leads one to believe that the sales are one month behind the production and thus even though Molycorp had been previously sending material to Silmet before the merger, it was only able to sell two months of material during this quarter. This merger delay in achieving full quarter sales leads to a difference in $13.4M or almost $.14 per share. Removing $.14 per share from my mid 60 cents per share 2Q estimate brings the estimate exactly in line with Molycorp’s report. This delay in realized earnings is a one-time event and will not need to be recorded in future estimates.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.